Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pericytes | 10 | 2024 | 293 | 3.760 |
Why?
|
Hypertension, Pulmonary | 17 | 2024 | 1578 | 3.040 |
Why?
|
Endothelial Cells | 15 | 2024 | 3548 | 1.190 |
Why?
|
Myocytes, Smooth Muscle | 4 | 2024 | 699 | 0.800 |
Why?
|
Pulmonary Artery | 7 | 2021 | 1927 | 0.730 |
Why?
|
Lung | 11 | 2024 | 10000 | 0.650 |
Why?
|
Chemokine CXCL12 | 1 | 2020 | 454 | 0.610 |
Why?
|
Neovascularization, Pathologic | 4 | 2019 | 2645 | 0.590 |
Why?
|
Education, Graduate | 1 | 2016 | 75 | 0.510 |
Why?
|
Cell Polarity | 2 | 2019 | 637 | 0.500 |
Why?
|
Writing | 1 | 2016 | 199 | 0.470 |
Why?
|
Cell Movement | 6 | 2019 | 5203 | 0.410 |
Why?
|
Wnt Proteins | 2 | 2016 | 718 | 0.380 |
Why?
|
Lung Diseases | 1 | 2021 | 1909 | 0.370 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1386 | 0.340 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1612 | 0.310 |
Why?
|
MicroRNAs | 3 | 2013 | 3816 | 0.300 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1117 | 0.290 |
Why?
|
Hepatitis B | 1 | 2012 | 705 | 0.270 |
Why?
|
Animals | 29 | 2024 | 168459 | 0.270 |
Why?
|
Mice | 19 | 2024 | 81525 | 0.250 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2016 | 1493 | 0.250 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 77 | 0.240 |
Why?
|
Pipecolic Acids | 1 | 2023 | 77 | 0.220 |
Why?
|
Neurogenic Inflammation | 1 | 2023 | 33 | 0.220 |
Why?
|
Coculture Techniques | 2 | 2019 | 1341 | 0.210 |
Why?
|
Interleukin-13 | 1 | 2024 | 392 | 0.200 |
Why?
|
beta Catenin | 4 | 2016 | 1040 | 0.200 |
Why?
|
Neurons, Afferent | 1 | 2023 | 498 | 0.180 |
Why?
|
Antithrombins | 1 | 2023 | 294 | 0.180 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 629 | 0.180 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2020 | 64 | 0.180 |
Why?
|
Arginine | 1 | 2023 | 934 | 0.170 |
Why?
|
Pneumonectomy | 2 | 2023 | 1119 | 0.170 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 2298 | 0.170 |
Why?
|
Benzylamines | 1 | 2020 | 247 | 0.160 |
Why?
|
Gene Products, nef | 1 | 2019 | 100 | 0.160 |
Why?
|
Heterocyclic Compounds | 1 | 2020 | 246 | 0.160 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2024 | 515 | 0.160 |
Why?
|
Mice, SCID | 2 | 2014 | 2626 | 0.150 |
Why?
|
Trachea | 2 | 2015 | 1089 | 0.150 |
Why?
|
Stomatitis, Aphthous | 1 | 2018 | 51 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1132 | 0.150 |
Why?
|
Bleomycin | 1 | 2019 | 494 | 0.150 |
Why?
|
Bacterial Toxins | 1 | 2023 | 931 | 0.150 |
Why?
|
Recombinant Proteins | 4 | 2023 | 6534 | 0.150 |
Why?
|
Cells, Cultured | 10 | 2019 | 18965 | 0.150 |
Why?
|
Paracrine Communication | 1 | 2019 | 277 | 0.140 |
Why?
|
Vasoconstriction | 1 | 2020 | 592 | 0.140 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18252 | 0.140 |
Why?
|
Interferon-alpha | 1 | 2021 | 921 | 0.140 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 2 | 2014 | 72 | 0.140 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2017 | 99 | 0.140 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2018 | 103 | 0.140 |
Why?
|
Proteoglycans | 1 | 2020 | 803 | 0.140 |
Why?
|
Signal Transduction | 8 | 2024 | 23445 | 0.140 |
Why?
|
Microvessels | 3 | 2017 | 577 | 0.140 |
Why?
|
Cell Hypoxia | 1 | 2019 | 656 | 0.140 |
Why?
|
Specimen Handling | 1 | 2021 | 702 | 0.130 |
Why?
|
Heparin | 1 | 2023 | 1634 | 0.130 |
Why?
|
Muscle Contraction | 1 | 2021 | 1201 | 0.130 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4320 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2469 | 0.130 |
Why?
|
Receptors, CXCR4 | 1 | 2020 | 727 | 0.120 |
Why?
|
Elafin | 1 | 2015 | 31 | 0.120 |
Why?
|
Methamphetamine | 1 | 2017 | 165 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2416 | 0.120 |
Why?
|
Pulmonary Circulation | 1 | 2018 | 737 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1961 | 0.120 |
Why?
|
Humans | 31 | 2024 | 761504 | 0.120 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 505 | 0.120 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2015 | 112 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2016 | 255 | 0.120 |
Why?
|
Neovascularization, Physiologic | 3 | 2016 | 1349 | 0.120 |
Why?
|
Antigens | 1 | 2020 | 1443 | 0.120 |
Why?
|
Frizzled Receptors | 1 | 2014 | 90 | 0.120 |
Why?
|
Exosomes | 1 | 2019 | 424 | 0.120 |
Why?
|
Fibroblasts | 1 | 2024 | 4141 | 0.110 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2014 | 187 | 0.110 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2016 | 411 | 0.110 |
Why?
|
Sulfonamides | 1 | 2023 | 1978 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2019 | 1175 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2020 | 9539 | 0.110 |
Why?
|
Hydrogels | 1 | 2019 | 720 | 0.110 |
Why?
|
Atherosclerosis | 2 | 2023 | 3408 | 0.110 |
Why?
|
3' Untranslated Regions | 2 | 2013 | 519 | 0.110 |
Why?
|
Integrin alpha3 | 1 | 2012 | 26 | 0.110 |
Why?
|
Receptor, TIE-2 | 1 | 2013 | 176 | 0.110 |
Why?
|
Microcirculation | 2 | 2015 | 1273 | 0.110 |
Why?
|
PPAR gamma | 1 | 2016 | 484 | 0.100 |
Why?
|
Leukotrienes | 1 | 2014 | 231 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1860 | 0.100 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 158 | 0.100 |
Why?
|
Cell Division | 1 | 2020 | 4465 | 0.100 |
Why?
|
Cyclosporine | 1 | 2015 | 778 | 0.100 |
Why?
|
Cell Transdifferentiation | 1 | 2013 | 185 | 0.100 |
Why?
|
Aspergillus fumigatus | 1 | 2013 | 157 | 0.100 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2012 | 153 | 0.100 |
Why?
|
Blotting, Western | 2 | 2016 | 5035 | 0.100 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 305 | 0.100 |
Why?
|
Magnetics | 1 | 2014 | 599 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 2018 | 980 | 0.090 |
Why?
|
Cell Lineage | 1 | 2020 | 2555 | 0.090 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2012 | 218 | 0.090 |
Why?
|
Mice, Inbred C57BL | 6 | 2023 | 22169 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1755 | 0.090 |
Why?
|
Drug Design | 1 | 2016 | 1048 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 619 | 0.080 |
Why?
|
Muscle Proteins | 1 | 2014 | 1154 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1667 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1051 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3778 | 0.070 |
Why?
|
Osteoblasts | 1 | 2013 | 1143 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1626 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11528 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1250 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6075 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7396 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1115 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2019 | 14414 | 0.070 |
Why?
|
Flow Cytometry | 1 | 2016 | 5869 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4511 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3429 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2425 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
Chronic Disease | 1 | 2020 | 9318 | 0.060 |
Why?
|
Rats | 2 | 2019 | 23742 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 12795 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2045 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12128 | 0.060 |
Why?
|
Organ Transplantation | 1 | 2015 | 1157 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11903 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2014 | 2024 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 22176 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9469 | 0.060 |
Why?
|
Cell Cycle | 1 | 2012 | 2932 | 0.060 |
Why?
|
Apoptosis | 3 | 2017 | 9486 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2016 | 10445 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2455 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2023 | 26198 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 75 | 0.050 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2023 | 134 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 223 | 0.050 |
Why?
|
Cecum | 1 | 2023 | 233 | 0.050 |
Why?
|
Hirudins | 1 | 2023 | 179 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4544 | 0.050 |
Why?
|
Trans-Activators | 1 | 2012 | 2856 | 0.050 |
Why?
|
Substance P | 1 | 2023 | 335 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 191 | 0.050 |
Why?
|
Endothelium, Vascular | 4 | 2016 | 4431 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2015 | 2917 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4445 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 560 | 0.050 |
Why?
|
Thrombin | 1 | 2023 | 591 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 366 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10773 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4936 | 0.050 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2023 | 323 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2024 | 1149 | 0.050 |
Why?
|
Genes, Reporter | 2 | 2016 | 1529 | 0.040 |
Why?
|
Adolescent | 3 | 2019 | 88319 | 0.040 |
Why?
|
Middle Aged | 6 | 2019 | 220895 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9420 | 0.040 |
Why?
|
Female | 11 | 2019 | 392644 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5796 | 0.040 |
Why?
|
Adult | 5 | 2019 | 221177 | 0.040 |
Why?
|
Male | 9 | 2019 | 360804 | 0.040 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 148 | 0.040 |
Why?
|
Child | 2 | 2019 | 80153 | 0.040 |
Why?
|
Pluripotent Stem Cells | 1 | 2024 | 799 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2015 | 3087 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1444 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 867 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9606 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1726 | 0.030 |
Why?
|
Clostridium Infections | 1 | 2023 | 558 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2016 | 178 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 2019 | 483 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16981 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 6216 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2023 | 1886 | 0.030 |
Why?
|
Anticoagulants | 2 | 2023 | 4812 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2016 | 435 | 0.030 |
Why?
|
Phosphorylation | 2 | 2016 | 8320 | 0.030 |
Why?
|
Leukocyte Elastase | 1 | 2015 | 114 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2084 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 257 | 0.030 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2014 | 128 | 0.030 |
Why?
|
Glycerophosphates | 1 | 2013 | 47 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2014 | 258 | 0.030 |
Why?
|
Complement C3 | 1 | 2015 | 435 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2015 | 592 | 0.030 |
Why?
|
Osteocalcin | 1 | 2013 | 274 | 0.030 |
Why?
|
Mutation | 2 | 2014 | 30052 | 0.030 |
Why?
|
COS Cells | 1 | 2014 | 1130 | 0.030 |
Why?
|
Gene Expression | 2 | 2016 | 7581 | 0.030 |
Why?
|
Chemotaxis | 1 | 2015 | 598 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3810 | 0.020 |
Why?
|
HIV | 1 | 2019 | 1582 | 0.020 |
Why?
|
Aspergillosis | 1 | 2013 | 242 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2015 | 754 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2023 | 5112 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1334 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2013 | 461 | 0.020 |
Why?
|
Perfusion | 1 | 2015 | 1373 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1738 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1496 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1171 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2016 | 1756 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22170 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2012 | 439 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2141 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1326 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1505 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2231 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2693 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1974 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1155 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2831 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2919 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1509 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8465 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2571 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11076 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5915 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6310 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1459 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5789 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7827 | 0.010 |
Why?
|
DNA Damage | 1 | 2014 | 2446 | 0.010 |
Why?
|
Graft Survival | 1 | 2015 | 3819 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 2009 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6965 | 0.010 |
Why?
|
Aged | 2 | 2018 | 169289 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2805 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12463 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3113 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4740 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7967 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2875 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5791 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2960 | 0.010 |
Why?
|
Genetic Testing | 1 | 2014 | 3537 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14666 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5671 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15266 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10194 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13506 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23995 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17904 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59243 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74206 | 0.010 |
Why?
|